Skip to main content
. 2020 Apr 8;9(2):341–353. doi: 10.1007/s40121-020-00294-6
Why carry out this study?
Pneumococcal vaccinations have been a part of the routine infant vaccination program throughout Canada since 2005.
The objective of this study was to estimate the historical public health and economic impact of infant pneumococcal vaccine programs in Canada between 2005 and 2015.
What was learned from this study?
PCV programs were estimated to have saved 6631 lives and averted 14,990 IPD cases, 735,700 pneumonia episodes, and 3,697,993 AOM episodes.
Canadian PCV programs have provided significant health benefits and resulted in a substantial value for money and a net savings over the reviewed period of approximately $1.76 billion.